Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2011
06/01/2011EP2099796B1 Aza-indolyl compounds and methods of use
06/01/2011DE102010042864A1 Substituierte Thioamide mit herbizider Wirkung Substituted thioamides with herbicidal activity
06/01/2011DE102010038714A1 Composition, useful for coloring keratin fibers, preferably human hair, comprises a cationic 1-(3-amino-benzyl)-4-aza-1-azonia-bicyclo( 2.2.2)octane phenylamine compound as developer component, in a carrier
06/01/2011CN1968753B Shaped body containing a microporous material and at least one silicon-containing binder, method for the production thereof and its use as a catalyst, particularly in a method for producing triethylen
06/01/2011CN102083834A 7H-indolo[2,1-a] [2] benzazepine-10-carboxylic acid derivatives for the treatment of hepatitis c
06/01/2011CN102083833A Substituted quinazolines as blood platelet lowering agents
06/01/2011CN102083814A Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
06/01/2011CN102083800A Heteroaryl compounds and uses thereof
06/01/2011CN102079746A Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors
06/01/2011CN101633675B Preparation and application of 5-substituent group-6-substituent phenyl-2-ferrocenyl pyrazolo [1, 5-a] pyrazine-4(5H)-ketone derivative
06/01/2011CN101525337B Oxidative desulfurization catalysts binuclear/trinuclear cobalt phthalocyanine carboxylate and preparation methods thereof
06/01/2011CN101407489B 2-alkyl acrylate compounds and uses thereof
06/01/2011CN101314603B Valine protected imidazo-[1,2-a] purine three-loop base opened-loop nucleoside compounds, preparation method and application thereof
05/2011
05/31/2011US7951958 Imidazole compounds for the treatment of neurodegenerative disorders
05/31/2011US7951941 Process for preparing 5-alkyl-7H-pyrrolo[2,3-d] pyrimindine-2-ols
05/31/2011US7951939 Methods and intermediates for the synthesis of porphyrins
05/31/2011US7951938 Fluorinated dyes or colorants and their uses
05/31/2011US7951820 Triazole compounds useful as protein kinase inhibitors
05/31/2011US7951812 For abnormal cell proliferation, inflammatory diseases, asthma, and arthritis; (S)-N-{4-[2-(2,4-diamino-7H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-4-methylene-L-glutamic acid disodium salt (CHL1007)
05/31/2011US7951811 Pyrrolo[2,3-D]pyrimidine derivatives substituted with a cyclic amino group
05/31/2011US7951810 Substituted pyrrolo[2,3-d]pyrimidines as inhibitors of E1 activating enzymes
05/31/2011US7951809 Inhibitors of p38
05/31/2011US7951804 Inhibitors of coagulation factors; Thrombosis, tumors, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis; example, 1-(4-chlorophenyl)-3-[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-phenylethyl]urea
05/31/2011US7951799 Lactam compound, a method for producing the same, and a diabetic therapy by administering the same
05/31/2011US7951791 Amino-substituted tricyclic derivatives and methods of use
05/31/2011CA2634299C Process for preparing inhibitors of nucleoside metabolism
05/31/2011CA2501365C Inhibitors of akt activity
05/31/2011CA2497450C Pyrazolopyrimidines as cyclin dependent kinase inhibitors
05/31/2011CA2480470C Inhibitors of nucleoside phosphorylases and nucleosidases
05/31/2011CA2465750C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]-indole-1-carboxamide derivatives, their preparation and therapeutic use
05/31/2011CA2429629C Ligand and complex for catalytically bleaching a substrate
05/31/2011CA2319080C Multivalent antibacterial agents
05/27/2011CA2686584A1 Plasmodium proteases inhibitors and in silico screening methods for identifying the same
05/26/2011WO2011062766A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
05/26/2011WO2011062253A1 Novel fused pyrimidine derivative
05/26/2011WO2011061679A1 Imidazo-pyrazoles as gpr119 inhibitors
05/26/2011WO2011039459A3 Suspensions of hexanitrohexaazaisowurtzitane crystals, production of said suspensions and production of pyrotechnic objects
05/26/2011WO2011028829A3 Organic electronic devices and polymers, including photovoltaic cells and diketone-based and diketopyrrolopyrrole-based polymers
05/26/2011WO2011028827A3 Organic electronic devices and polymers, including photovoltaic cells and diketone-based polymers
05/26/2011WO2011011186A3 Hdac inhibitors and therapeutic methods using the same
05/26/2011US20110126300 High Through-Put Method of Screening Compounds for Pharmacological Activity
05/26/2011US20110124869 Process for Preparing Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
05/26/2011US20110124862 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists
05/26/2011US20110124861 Process for Preparing Pemetrexed Disodium and Its Intermediate, 4-(4-Carbomethoxyphenyl) Butanal
05/26/2011US20110124641 Benzothiazole kinase inhibitors and methods of use
05/26/2011US20110124640 Fused heterocyclic compounds useful as kinase modulators
05/26/2011US20110124634 Bioactive compounds for treatment of cancer and neurodegenerative diseases
05/26/2011US20110124623 Pyrrolotriazine kinase inhibitors
05/26/2011US20110124622 Isoindolones derivatives as mek kinase inhibitors and methods of use
05/26/2011US20110124619 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
05/26/2011DE102009053836A1 Materialien für organische Elektrolumineszenzvorrichtungen Materials for organic electroluminescent
05/26/2011CA2781287A1 Compounds and methods for kinase modulation, and indications therefor
05/26/2011CA2780463A1 Imidazo-pyrazoles as gpr119 inhibitors
05/26/2011CA2780287A1 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
05/25/2011EP2325186A2 Fused Bicyclic mTor Inhibitors
05/25/2011EP2325169A2 Lisofylline analogues and their pharmeacuetical uses
05/25/2011EP2324030A1 Explosive
05/25/2011EP2324029A2 Heterocyclic inhibitors of histamine receptors for the treatment of disease
05/25/2011EP2324028A2 Therapeutic agents 414
05/25/2011EP2324027A2 New crystalline salt forms of a 5,6,7,8-tetrahydro-1,2,4- triazolo[4,3-a]pyrazine derivative
05/25/2011EP2324022A1 Substituted naphthyridines and use thereof as medicines
05/25/2011EP2324021A1 Diazaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
05/25/2011EP2324020A2 Piperidine derivatives as jak3 inhibitors
05/25/2011EP2323987A1 N-myristoyl transferase inhibitors
05/25/2011EP2323981A1 Process for the preparation of a macrocycle
05/25/2011EP2323665A1 Fused heterocyclic compounds useful as kinase modulators
05/25/2011EP2323663A1 4-amino-3-(imidazolyl)-pyrazolo[3,4-d]pyrimidines
05/25/2011EP2212297B1 Inhibitors of protein kinases
05/25/2011EP2125748B1 Acylaminopyrazoles as fgfr inhibitors
05/25/2011CN1930166B 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and compositions containing said compounds
05/25/2011CN1832938B N-heterocyclyl phenyl-substituted cyclic ketoenols
05/25/2011CN1771231B Calcium receptor modulating compound and use thereof
05/25/2011CN1578663B Inhibitors of histone deacetylase
05/25/2011CN102076698A 2h- pyrimido [2, 1-b] quinaz0lin-2-0ne derivatives and their use as platelet anti-aggregative agents
05/25/2011CN102076697A Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases
05/25/2011CN102076696A Substituted quinazolines
05/25/2011CN102076695A Imidazoquinazoline derivatives as anagrelide analogues for the treatment of myeloprolific diseases and thrombotic diseases
05/25/2011CN102076694A 5, 6, 7, 8-tetrahydro-imidazo[1, 5-a]pyrazine compounds
05/25/2011CN102076693A Substituted tricyclic derivatives against neurodegenerative diseases
05/25/2011CN102076692A Triazolo [4, 5-D] pyramidine derivatives and their use as purine receptor antagonists
05/25/2011CN102076691A Protein kinase inhibitors
05/25/2011CN102076690A Protein kinase inhibitors
05/25/2011CN102076689A Pyrazolo-quinazolines
05/25/2011CN102076687A Substituted quinazolines as blood platelet lowering agents
05/25/2011CN102076680A Benzoimidazoles as prolyl hydroxylase inhibitors
05/25/2011CN102070642A Novel method for directly synthesizing cobalt phthalocyanine crystals
05/25/2011CN102070641A Monosubstituted metal phthalocyanine and synthesis and separation method and application thereof
05/25/2011CN102070640A Method for synthesizing 1,7-diazaspiro[4.5]nonane and derivatives thereof
05/25/2011CN102070639A Method for synthesizing temozolomide
05/25/2011CN102070638A Preparation method of hexahydro-pyrrolo [3,4-c] pyrrole-1-ketone derivative
05/25/2011CN102068436A Dihydroporphin photosensitizer and preparation and application thereof
05/25/2011CN102068428A Dihydroporphin photosensitizer and preparation and application thereof
05/25/2011CN101560214B 4-amino-6-phenyl-pyrrolo[2, 3-d]pyrimidine derivatives
05/25/2011CN101160308B Pharmacetically acceptable salt with decoquinate ketone compound with improved medicine performance
05/25/2011CN101133055B MELEIMId derivative for treating cancer, compositions and methods
05/24/2011US7947844 One-pot synthesis of benzisoindolenines used in the preparation of naphthalocyanines
05/24/2011US7947829 Method of making porphyrins
05/24/2011US7947827 Pharmaceutical formulation comprising a metaloporphyrin and method for its purification and use
05/24/2011US7947826 Wet film filming
05/24/2011US7947825 Process for making titanyl phthalocyanine